President Donald Trump on May 12 confirmed that Marty Makary, the embattled FDA commissioner criticized by pro-life advocates and others, will leave his post.
Susan B. Anthony Pro-Life America
-
-
SBA commits to $160 million in midterm and 2028 elections spending amid growing challenges
by Kate Scanlonby Kate ScanlonThe Trump administration has left in place the Biden administration’s eased restrictions on mifepristone that eliminated an in-person dispensing requirement.
-
States and jurisdictions are not required to report their abortion data to the Centers for Disease Control’s Abortion Surveillance System.
-
Pro-life groups urge DOJ to stop opposing state abortion pill lawsuits
by Kate Scanlonby Kate ScanlonThe state lawsuits seek to end the FDA policy implemented during the Biden administration permitting mifepristone to be distributed by mail.
-
Key pro-life group warns lack of action on Hyde, mifepristone may ‘demotivate’ Republican voters
by Kate Scanlonby Kate ScanlonA key national pro-life group released polling it said shows a potential failure to act on pro-life policy priorities may demotivate Republican primary voters in the upcoming midterm elections.
-
Trump administration asks federal court to pause Louisiana’s abortion pill challenge
by Kate Scanlonby Kate ScanlonA key pro-life group said the Justice Department is undermining Louisiana’s efforts to roll back the Biden administration’s restrictions on the abortion pill.
-
Key pro-life leader says ‘harsh reality’ demands Trump-Vance ‘act’ on abortion after March for Life
by Kate Scanlonby Kate ScanlonMarjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, criticized the Trump administration on abortion in a statement after the March for Life.
-
Key pro-life organization pushes Trump on Hyde, mifepristone, ahead of March for Life
by Kate Scanlonby Kate ScanlonIn a press call just before the 53rd annual March for Life, a key national pro-life organization pushed the Trump administration to safeguard the Hyde Amendment and reinstate stronger restrictions …
-
Senate hearing examines abortion pill after FDA approval of new generic version
by Kate Scanlonby Kate ScanlonA Senate committee held a hearing on the abortion pill Jan. 14 as the Trump administration faces scrutiny from some pro-lifers over the Food and Drug Administration’s recent approval of …
-
The Trump administration “quietly released” Title X family planning funds to Planned Parenthood, the nation’s largest abortion provider in December.
>